查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
密苏里州医用大麻市场规模、份额、趋势分析：产品（花、油/酊剂）、应用（慢性疼痛、抽动秽语综合征）、分部预测，2022-2030
市场调查报告书
商品编码
1097060

密苏里州医用大麻市场规模、份额、趋势分析：产品（花、油/酊剂）、应用（慢性疼痛、抽动秽语综合征）、分部预测，2022-2030

Missouri Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flower, Oils & Tinctures), By Application (Chronic Pain, Tourette's), And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

密苏里州医用大麻市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，密苏里州的医用大麻市场预计到 2030 年将达到 20.2 亿美元。

从 2022 年到 2030 年，CAGR 预计将增长 22.7%。越来越多的大麻健康益处证据、患者对这些益处的了解增加以及慢性病患病率增加是市场增长的关键驱动力。此外，自 2018 年 11 月以来，密苏里州已获得医用大麻种植、加工、製造和分销的许可。从那时起，医用大麻的销量猛增，推动了该州的增长。

从应用来看，由于患者数量众多，慢性疼痛领域占有绝对优势，2021年市场份额超过25.0%。慢性疼痛包括神经源性问题、关节炎、腰痛、癌症、头痛、颈部问题和麵部问题。据说医用大麻可以拯救遭受痛苦的人。随着越来越多的人了解摄入大麻产品的重要性和益处，预计该市场将在预测期内增长。

按产品划分，油酊剂占 2021 年收益的最大份额。该细分市场增长的关键因素包括使用油和酊剂而不是花烟熏带来的好处和易用性。由于接受诸如创伤后应激障碍、癫痫、自闭症和慢性疼痛等健康状况治疗的患者的需求增加，预计该部分在预测期内将以最快的速度增长。

几乎在所有企业中，COVID-19 大流行导致大规模倒闭，扰乱日常运营并影响消费者行为。由于对 COVID-19 的反对增加，该零售店已关闭。由于中国、印度等主要原材料生产国物流停工，市场开始出现供应短缺现象。此外，美国各地的供应链中断给额外原材料的供应带来了沉重负担，限制了市场增长。它还影响了大麻产品的生产，扰乱了该州的医用大麻供应链。

密苏里州医用大麻市场报告亮点

  • 医用大麻的合法化和资质的提高可能会推动密苏里州的市场增长。
  • 受大麻提取物需求增加、用于治疗各种慢性病的大麻合法化、大麻提取物产品新□□上市等因素影响，2021年油和酊剂产品领域将超过50.0%。获得的收入份额和主导市场
  • 按应用来看，2021 年慢性疼痛以超过 25.0% 的收入份额引领市场。这是由于药用大麻因其脱敏和抗炎特性而越来越多地用作急性疼痛的有效治疗方法。

目录

第一章调查方法及范围

  • 调查方法
  • 调查范围和先决条件
  • 数据源列表

第2章执行摘要

  • 市场展望

第 3 章密苏里州医用大麻市场的变量、趋势和范围

  • 市场细分
  • 密苏里州医用大麻市场动态
    • 市场促进因素分析
    • 市场製约因素分析
  • 渗透率和增长前景映射
  • 密苏里州医用大麻市场分析工具
    • 密苏里州医用大麻市场 PESTLE 分析
      • 政治和法律状况
      • 环境状况
      • 社会状况
      • 技术情况
    • 行业分析-波特
      • 供应商实力：中等
      • 买方议价能力：低
      • 替代威胁：低
      • 来自新进入者的威胁：中
      • 竞争对手之间的敌对关係：略高
    • 监管场景
    • 市场机会分析
    • COVID-19 对市场的影响

第 4 章密苏里州医用大麻市场：产品估计和趋势分析

  • 密苏里州医用大麻市场：产品波动分析
  • 花
    • 2018-2030 年花卉市场估计/预测（100 万美元）
  • 油/酊剂
    • 2018-2030 年石油和酊剂市场估计和预测（100 万美元）

第 5 章密苏里州医用大麻市场：使用估计和趋势分析

  • 密苏里州医用大麻市场：使用波动分析
  • 癌症
    • 2018-2030 年癌症市场估计/预测（100 万美元）
  • 慢性疼痛
    • 2018-2030 年慢性疼痛市场估计/预测（100 万美元）
  • 抑郁和焦虑
    • 2018-2030 年抑郁症和焦虑症的市场估计和预测（100 万美元）
  • 关节炎
    • 2018-2030 年关节炎市场估计/预测（100 万美元）
  • 糖尿病
    • 2018-2030 年糖尿病市场估计和预测（100 万美元）
  • 青光眼
    • 2018-2030 年青光眼市场估计和预测（100 万美元）
  • 偏头痛
    • 2018-2030 年偏头痛市场估计和预测（100 万美元）
  • 癫痫
    • 2018-2030 年癫痫市场估计/预测（100 万美元）
  • 多发性硬化症
    • 2018-2030 年多发性硬化症市场估计和预测（100 万美元）
  • 艾滋病
    • 2018-2030 年艾滋病市场估计和预测（100 万美元）
  • 肌萎缩侧索硬化症
    • 2018-2030 年肌萎缩侧索硬化症市场估计和预测（100 万美元）
  • 阿尔茨海默病
    • 2018-2030 年阿尔茨海默病市场估计和预测（100 万美元）
  • 创伤后应激障碍
    • 2018-2030 年创伤后应激障碍市场估计和预测（100 万美元）
  • 帕金森病
    • 2018-2030 年帕金森病市场估计和预测（100 万美元）
  • 抽动秽语综合征
    • 2018-2030 年妥瑞氏综合症市场估计和预测（100 万美元）
  • 其他
    • 2018-2030 年其他市场估计/预测（100 万美元）

第6章竞争态势

  • 公司简介
      • BeLeaf 医疗
        • 公司简介
        • 财务表现
        • 战略举措
      • 蓝鼠尾草大麻公司。
        • 公司简介
        • 财务表现
        • 战略举措
      • 显示替代方案
        • 公司简介
        • 财务表现
        • 战略举措
      • 禾雅养生
        • 公司简介
        • 财务表现
        • 战略举措
      • 密苏里狂野炼金术
        • 公司简介
        • 财务表现
        • 战略举措
      • 有机疗法
        • 公司简介
        • 财务表现
        • 战略举措
      • 整体产业
        • 公司简介
        • 财务表现
        • 战略举措
      • 堪萨斯城大麻
        • 公司简介
        • 财务表现
        • 战略举措
      • 当地大麻公司
        • 公司简介
        • 财务表现
        • 战略举措
      • MOcann 提取物
        • 公司简介
        • 财务表现
        • 战略举措
Product Code: GVR-3-68038-978-4

Missouri Medical Cannabis Market Growth & Trends:

The Missouri medical cannabis market size is expected to reach USD 2.02 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.7% from 2022 to 2030. Growing evidence of marijuana's health advantages, rising patient knowledge regarding these benefits, and an increase in the prevalence of chronic conditions are the major factors contributing to the market growth. In addition, since November 2018, Missouri has allowed the cultivation, processing, manufacturing, and distribution of medical cannabis. Since then, a sharp rise has been witnessed in the sales of medical cannabis, thereby impelling the growth in the state.

Based on application, the chronic pain segment dominated the market in 2021 with a share of over 25.0% owing to a large patient pool. Pains associated with neurogenic issues, arthritis, low back issues, cancer, headache, neck-related issues, and face-related issues are just a few of the several types of chronic pain. Medical marijuana has been said to help people who are suffering from pain. The market is likely to witness growth during the forecast period as a growing number of people are understanding the importance and benefits of the intake of cannabis-based products.

Based on product, the oils and tinctures segment accounted for the largest revenue share in 2021. Some of the major factors responsible for the segment growth are benefits provided by the utilization of oils and tinctures over smoking flowers and ease of use. In addition, this segment is anticipated to grow at the fastest rate during the forecast period owing to its increasing demand from patients undergoing treatment for health conditions such as PTSD, epilepsy, autism, and chronic pain.

In practically every business, the COVID-19 pandemic has resulted in massive lockdowns, disrupting daily operations and affecting consumer behavior. Retail stores have been closed as the backlash to COVID-19 grows. Due to the suspension of the logistics industry in major raw material-producing countries such as China and India, the market began to experience a supply deficit. Furthermore, supply chain interruptions across the U.S. has led to a tremendous strain on the supply of additional raw materials, thereby constraining the market growth. In addition, this has impacted the manufacturing of cannabis products, and hence the supply chain for medical cannabis in the state has been disrupted.

Missouri Medical Cannabis Market Report Highlights:

  • The legalization of marijuana for medical purposes and the increasing number of people who qualify are likely to bolster the market growth in Missouri
  • Due to factors such as the rising demand for cannabis extracts, the legalization of marijuana for the treatment of various chronic diseases, and new cannabis extract product launches, the oil and tinctures product segment dominated the market in 2021 with a revenue share of over 50.0%
  • By application, chronic pain led the market with a revenue share of over 25.0% in 2021. This is due to a growth in the use of medicinal cannabis as an efficient therapy for acute pain owing to its ability to dull the perceptions and anti-inflammatory qualities

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Scope and Assumptions
  • 1.3 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Missouri Medical Cannabis Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Missouri Medical Cannabis Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Penetration & Growth Prospects Mapping
  • 3.4 Missouri Medical Cannabis Market Analysis Tools
    • 3.4.1 Missouri Medical Cannabis Market - PESTLE Analysis
      • 3.4.1.1 Political & Legal Landscape
      • 3.4.1.2 Environmental Landscape
      • 3.4.1.3 Social Landscape
      • 3.4.1.4 Technology Landscape
    • 3.4.2 Industry Analysis - Porter's
      • 3.4.2.1 Supplier Power: Moderate
      • 3.4.2.2 Buyer Power: Low
      • 3.4.2.3 Substitution Threat: Low
      • 3.4.2.4 Threat from New Entrants: Moderate
      • 3.4.2.5 Competitive Rivalry: Moderately High
    • 3.4.3 Regulatory Scenario
    • 3.4.4 Opportunity Analysis
    • 3.4.4 Impact of COVID-19 on the market

Chapter 4 Missouri Medical Cannabis Market: Product Estimates & Trend Analysis

  • 4.1 Missouri Medical Cannabis Market: Product Movement Analysis
  • 4.2 Flower
    • 4.2.1 Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Oils and Tinctures
    • 4.3.1 Oils & Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Missouri Medical Cannabis Market: Application Estimates & Trend Analysis

  • 5.1 Missouri Medical Cannabis Market: Application Movement Analysis
  • 5.2 Cancer
    • 5.2.1 Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Chronic Pain
    • 5.3.1 Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Depression & Anxiety
    • 5.4.1 Depression & Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Arthritis
    • 5.5.1 Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Diabetes
    • 5.6.1 Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Glaucoma
    • 5.7.1 Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8 Migraines
    • 5.8.1 Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9 Epilepsy
    • 5.9.1 Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10 Multiple Sclerosis
    • 5.10.1 Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11 AIDS
    • 5.11.1 AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12 Amyotrophic Lateral Sclerosis
    • 5.12.1 Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.13 Alzheimer's Disease
    • 5.13.1 Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.14 Post-Traumatic Stress Disorder
    • 5.14.1 Post-Traumatic Stress Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.15 Parkinson's Disease
    • 5.15.1 Parkinson's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.16 Tourette's Syndrome
    • 5.16.1 Tourette's Syndrome Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.17 Others
    • 5.17.1 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Company Profiles
    • 6.1.1 BeLeaf Medical
      • 6.1.1.1 Company overview
      • 6.1.1.2 Financial performance
      • 6.1.1.3 Strategic initiatives
    • 6.1.2 . Blue Sage Cannabis Co.
      • 6.1.2.1 Company overview
      • 6.1.2.2 Financial performance
      • 6.1.2.3 Strategic Initiatives
    • 6.1.3 Show Me Alternatives
      • 6.1.3.1 Company overview
      • 6.1.3.2 Financial performance
      • 6.1.3.3 Strategic Initiatives
    • 6.1.4 Heya Wellness
      • 6.1.4.1 Company overview
      • 6.1.4.2 Financial performance
      • 6.1.4.3 Strategic Initiatives
    • 6.1.5 Missouri Wild Alchemy
      • 6.1.5.1 Company overview
      • 6.1.5.2 Financial performance
      • 6.1.5.3 Strategic Initiatives
    • 6.1.6 Organic Remedies
      • 6.1.6.1 Company overview
      • 6.1.6.2 Financial performance
      • 6.1.6.3 Strategic Initiatives
    • 6.1.7 Holistic Industries
      • 6.1.7.1 Company overview
      • 6.1.7.2 Financial performance
      • 6.1.7.3 Strategic Initiatives
    • 6.1.8 Kansas City Cannabis
      • 6.1.8.1 Company overview
      • 6.1.8.2 Financial performance
      • 6.1.8.3 Strategic Initiatives
    • 6.1.9 LOCAL CANNABIS COMPANY
      • 6.1.9.1 Company overview
      • 6.1.9.2 Financial performance
      • 6.1.9.3 Strategic Initiatives
    • 6.1.10 MOcann Extracts
      • 6.1.10.1 Company overview
      • 6.1.10.2 Financial performance
      • 6.1.10.3 Strategic Initiatives

List of Tables

  • Table. 1 Missouri medical cannabis market, by product, 2018 - 2030 (USD Million)
  • Table. 2 Missouri medical cannabis market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Missouri medical cannabis market snapshot, 2021 (USD Million)
  • Fig. 2 Missouri medical cannabis market segmentation
  • Fig. 3 Missouri medical cannabis market dynamics
  • Fig. 4 Missouri medical cannabis market driver impact
  • Fig. 5 Missouri medical cannabis market restraints impact
  • Fig. 6 Penetration & growth prospects mapping for medical cannabis
  • Fig. 7 Missouri medical cannabis market: Opportunity analysis
  • Fig. 8 Missouri medical cannabis market, Product outlook: Key takeaways
  • Fig. 9 Missouri medical cannabis market: Product movement analysis (2021 & 2030) (USD Million)
  • Fig. 10 Flower market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 11 Oils & Tinctures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 12 Missouri medical cannabis market, application outlook: Key takeaways
  • Fig. 13 Missouri medical cannabis market: application movement analysis (2021 & 2030)
  • Fig. 14 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Chronic pain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Depression & Anxiety market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Arthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Glaucoma market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Migraines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Epilepsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Multiple Sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 AIDS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Alzheimer's Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Post-Traumatic Stress Disorder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Parkinson's Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Tourette's Syndrome market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)